Vaccinex (VCNX) Misses Q3 EPS by 83c

Vaccinex (NASDAQ: VCNX) reported Q3 EPS of ($1.09), $0.83 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $20 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vaccinex (VCNX) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• UiPath Inc. (PATH) Reports In-Line Q2 EPS; offers guidance
• Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance